Massive counterfeit drug seizures and rising hospital violence underscore the urgent need for supply chain transparency and robust institutional protections to safeguard patient care.
A major pharmaceutical repacking racket busted in Karnataka has led to the suspension of dozens of licenses, including a Pfizer depot, raising serious international quality control concerns.
As Vermont manages $38 million in opioid settlement funds, a state-level restriction on law enforcement spending is leaving rural communities vulnerable to rising fentanyl trafficking.
Scientists have identified extrachromosomal DNA (ecDNA) as a key factor in how tumors evolve and resist chemotherapy. These circular DNA fragments carry oncogenes and replicate independently, allowing cancer cells to…
A collaborative study between Roche and Harvard University has led to the discovery of Zosurabalpin, a new antibiotic class that effectively kills carbapenem-resistant Acinetobacter baumannii. The drug works by inhibiting…
Insilico Medicine has advanced the first generative AI-discovered and AI-designed drug candidate into Phase II clinical trials. The drug, INS018_055, targets idiopathic pulmonary fibrosis, a chronic condition that causes progressive…
Vertex Pharmaceuticals has successfully completed Phase 3 trials for suzetrigine, a novel non-opioid pain medication. By targeting specific sodium channels in the peripheral nervous system, the drug blocks pain signals…
Researchers have utilized explainable deep learning to discover a new class of antibiotics capable of killing methicillin-resistant Staphylococcus aureus (MRSA). This breakthrough marks one of the first times AI has…
The Trump administration has successfully narrowed the FDA approval for the drug leucovorin, focusing on a rare genetic brain disorder. This move follows a rigorous review process that prioritized the…
